News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

R-Tech Ueno: Basic Agreement on the Supply of Recombinant Human Serum Albumin



10/18/2011 9:11:44 AM

TOKYO--(BUSINESS WIRE)--R-Tech Ueno (JASDAQ:4573) and Novozymes Biopharma DK A/S (hereinafter referred to as Novozymes) reached a basic agreement today on the supply of recombinant human serum albumin as described below:

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES